A chromatin-informed transcriptional regulatory framework to stratify patients and guide therapy selection in triple-negative breast cancer.

Bahl S, Dogan-Artun N, Nguyen J, Mahmoud H, Ba-Alawi W, Madani Tonekaboni SA, Kang KK, McGuire M, Tobin C, Silvester J, Savage P, Cressot L, Nand A, Feng G, Guilhamon P, Mer AS, Arlidge C, Elliott MJ, Park M, Cescon DW, Haibe-Kains B, Lupien M